TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Top Cited Papers
- 25 March 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (15), 6021-6026
- https://doi.org/10.1073/pnas.1303607110
Abstract
Malignant cells, like all actively growing cells, must maintain their telomeres, but genetic mechanisms responsible for telomere maintenance in tumors have only recently been discovered. In particular, mutations of the telomere binding proteins alpha thalassemia/mental retardation syndrome X-linked (ATRX) or death-domain associated protein (DAXX) have been shown to underlie a telomere maintenance mechanism not involving telomerase (alternative lengthening of telomeres), and point mutations in the promoter of the telomerase reverse transcriptase (TERT) gene increase telomerase expression and have been shown to occur in melanomas and a small number of other tumors. To further define the tumor types in which this latter mechanism plays a role, we surveyed 1,230 tumors of 60 different types. We found that tumors could be divided into types with low (TERT promoter mutations. The nine TERT-high tumor types almost always originated in tissues with relatively low rates of self renewal, including melanomas, liposarcomas, hepatocellular carcinomas, urothelial carcinomas, squamous cell carcinomas of the tongue, medulloblastomas, and subtypes of gliomas (including 83% of primary glioblastoma, the most common brain tumor type). TERT and ATRX mutations were mutually exclusive, suggesting that these two genetic mechanisms confer equivalent selective growth advantages. In addition to their implications for understanding the relationship between telomeres and tumorigenesis, TERT mutations provide a biomarker that may be useful for the early detection of urinary tract and liver tumors and aid in the classification and prognostication of brain tumors.Keywords
This publication has 47 references indexed in Scilit:
- Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of gliomaNeuro-Oncology, 2011
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer SubtypesThe American Journal of Pathology, 2011
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaNature Genetics, 2011
- Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersThe Lancet Neurology, 2010
- HPV E6 protein interacts physically and functionally with the cellular telomerase complexProceedings of the National Academy of Sciences, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Telomere and telomerase in stem cellsBritish Journal of Cancer, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994